ICD-10-CM Billable Code

M11.849

Other specified crystal arthropathies, unspecified hand

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 Code M11.849 refers to a category of joint disorders known as crystal arthropathies that affect the hand. These conditions are characterized by the formation of crystal deposits within the joints, leading to inflammation and pain. The 'other specified' designation indicates that the condition has specific features identified by healthcare professionals but does not fall into the more common types of crystal arthropathies like gout or pseudogout. This code helps in accurately diagnosing and documenting cases where crystals cause joint problems in the hand, ensuring appropriate treatment and management.

Causes & Symptoms

Clinical Causes: Accumulation of uric acid crystals in the joint tissues, often associated with gout. Presence of calcium pyrophosphate dihydrate (CPPD) crystals leading to pseudogout. Other less common crystalline deposits, such as cholesterol or hydroxyapatite crystals. Genetic predispositions that affect crystal metabolism or joint health. Chronic kidney disease, which can impair crystal clearance from the body. History of joint trauma or injury that may predispose to crystal deposition.

Key Symptoms: Sudden episodes of intense joint pain, typically affecting the fingers or other parts of the hand. Swelling and redness around the affected joint. Warmth and tenderness in the affected area. Reduced range of motion or stiffness in the fingers or hand joints. Possible formation of tophi, which are deposits of crystals under the skin around the joints. Intermittent flare-ups with symptom-free periods in between.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical examination and laboratory tests. Synovial fluid analysis is crucial, where fluid extracted from the affected joint is examined under a microscope to identify the specific type of crystal responsible. Blood tests may be performed to measure uric acid or calcium levels, helping to distinguish between different types of crystal arthropathies. Imaging studies like X-rays may reveal joint damage or deposits of crystals, aiding in confirming the diagnosis.

Treatment Protocols: Management of crystal arthropathies in the hand typically includes medication and lifestyle adjustments. Anti-inflammatory drugs, such as NSAIDs, are used to reduce pain and swelling during flare-ups. Colchicine may be prescribed to prevent future attacks, while corticosteroids can be administered directly into the joint or systemically for severe inflammation. Long-term strategies involve controlling underlying factors like uric acid levels through diet, medication, or lifestyle changes. Physical therapy may help maintain joint function and reduce stiffness. In some cases, surgical intervention might be necessary to remove crystal deposits or damaged tissue.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.849 a billable ICD-10 code?
Yes, M11.849 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.849?
Clinical documentation must specify the nature of Other specified crystal arthropathies, unspecified hand and any associated comorbidities for accurate reporting.

Cite this Clinical Reference